- Home
- ACLX
ACLX
Arcellx Inc.
as of 01-13-2026 3:35pm EST
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | REDWOOD CITY |
| Market Cap: | 3.7B | IPO Year: | 2022 |
| Target Price: | $113.75 | AVG Volume (30 days): | 890.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.94 | EPS Growth: | N/A |
| 52 Week Low/High: | $47.86 - $94.07 | Next Earning Date: | 02-26-2026 |
| Revenue: | $35,898,000 | Revenue Growth: | -76.96% |
| Revenue Growth (this year): | -68.36% | Revenue Growth (next year): | 293.08% |
AI-Powered ACLX Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Arcellx Inc. (ACLX)
CHIEF MEDICAL OFFICER
Avg Cost/Share
$64.15
Shares
6,131
Total Value
$393,285.87
Owned After
37,068
SEC Form 4
CHIEF MEDICAL OFFICER
Avg Cost/Share
$90.00
Shares
340
Total Value
$30,600.00
Owned After
37,068
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Heery Christopher | ACLX | CHIEF MEDICAL OFFICER | Jan 12, 2026 | Sell | $64.15 | 6,131 | $393,285.87 | 37,068 | |
| Heery Christopher | ACLX | CHIEF MEDICAL OFFICER | Nov 17, 2025 | Sell | $90.00 | 340 | $30,600.00 | 37,068 |
Compare ACLX vs Leading Stocks
See how ACLX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "ACLX Arcellx Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.